医疗设备制造商银休特（Insulet）今日盘中大涨5.25%，股价表现引人注目。该公司最新公布的第三季度财报超出市场预期，同时上调了全年业绩指引，这些积极因素推动了股价的上涨。
根据公司财报，银休特第三季度总收入同比增长29.9%，达到7.063亿美元，超过分析师预期的6.7673亿美元。调整后每股收益为1.24美元，同样高于市场预期的1.14美元。这一亮眼业绩主要得益于公司旗下可穿戴式胰岛素泵Omnipod的强劲需求。
展望未来，银休特上调了2025年全年业绩指引。公司预计年收入将比去年同期增长28%至29%，高于此前24%至27%的预期。其中，Omnipod的年收入增长预期被上调至29%至30%。这一乐观展望进一步提振了投资者信心，推动股价上涨。银休特的业绩表现和未来前景反映了医疗设备行业，特别是糖尿病管理领域的持续增长潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.